A detailed history of Corundum Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Corundum Group, Inc. holds 42,741 shares of PFE stock, worth $1.13 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
42,741
Previous 53,561 20.2%
Holding current value
$1.13 Million
Previous $1.5 Million 17.49%
% of portfolio
0.57%
Previous 0.59%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $299,714 - $339,639
-10,820 Reduced 20.2%
42,741 $1.24 Million
Q2 2024

Jul 17, 2024

BUY
$25.26 - $29.6 $321,433 - $376,660
12,725 Added 31.16%
53,561 $1.5 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $469,981 - $539,688
18,153 Added 80.03%
40,836 $1.13 Million
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $369,295 - $479,674
-14,133 Reduced 38.39%
22,683 $653,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $7,123 - $8,327
-222 Reduced 0.6%
36,816 $1.22 Million
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $189,485 - $219,230
-5,246 Reduced 12.41%
37,038 $1.36 Million
Q1 2023

Apr 24, 2023

BUY
$39.39 - $51.28 $477,131 - $621,154
12,113 Added 40.15%
42,284 $1.73 Million
Q4 2022

Jan 12, 2023

BUY
$41.75 - $54.5 $27,805 - $36,297
666 Added 2.26%
30,171 $1.55 Million
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $33,870 - $41,347
774 Added 2.69%
29,505 $1.29 Million
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $77,425 - $91,802
1,664 Added 6.15%
28,731 $1.51 Million
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $253,043 - $313,552
5,531 Added 25.68%
27,067 $1.4 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $89,829 - $133,157
2,174 Added 11.23%
21,536 $1.27 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $30,497 - $39,176
777 Added 4.18%
19,362 $833,000
Q2 2021

Aug 02, 2021

BUY
$35.91 - $40.68 $34,724 - $39,337
967 Added 5.49%
18,585 $728,000
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $14,568 - $16,429
435 Added 2.53%
17,618 $638,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $16,601 - $21,109
496 Added 2.97%
17,183 $633,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $529,812 - $621,590
16,687 New
16,687 $581,000
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $506,444 - $594,174
-15,951 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$30.12 - $36.54 $480,444 - $582,849
15,951 New
15,951 $494,000
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $493,787 - $599,036
-16,394 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $443,129 - $633,136
16,394 New
16,394 $535,000
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $445,778 - $636,921
-16,492 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$32.92 - $37.36 $9,382 - $10,647
285 Added 1.76%
16,492 $646,000
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $526,565 - $682,800
16,207 New
16,207 $552,000
Q3 2019

Oct 30, 2019

SELL
$32.49 - $42.13 $526,727 - $683,011
-16,212 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$36.98 - $41.52 $30,064 - $33,755
813 Added 5.28%
16,212 $702,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $368,025 - $404,336
-9,814 Reduced 38.92%
15,399 $654,000
Q4 2018

Feb 19, 2019

BUY
$38.47 - $43.86 $395,587 - $451,012
10,283 Added 68.87%
25,213 $1.1 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $2,869 - $3,058
87 Added 0.59%
14,930 $542,000
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $10,115 - $11,735
317 Added 2.18%
14,843 $527,000
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $266 - $282
8 Added 0.06%
14,526 $526,000
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $450,058 - $495,789
14,518
14,518 $518,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Corundum Group, Inc. Portfolio

Follow Corundum Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.